DonaldTrumpMDFACP

Oncology • Fairfax, VA

Genitourinary Oncology, Hematologic Oncology

CEO Inova Dwight & Martha Schar Cancer Institute Professor of Oncology, Roswell Park Cancer Institute

Join to view full profile

Dr. Trump is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Trump's full profile

Already have an account?

Office
3225 Gallows Rd
Fairfax, VA 22031
Phone+1 571-472-0221

Fax+1 571-472-0241

Education & Training

Johns Hopkins UniversityResidency, Internal Medicine, 1970 - 1975
Johns Hopkins University School of MedicineClass of 1970

Certifications & Licensure

NY State Medical License 2002 - Present
PA State Medical License Current
VA State Medical License 2015 - 2026
NC State Medical License 1988 - 1998
WI State Medical License 1981 - 1995
MD State Medical License 1970 - 1983

Awards, Honors, & Recognition

America's Top Doctors Castle Connolly, 2009-2014
Buffalo Spree Magazine Castle Connolly, 2008, 2010-2014
America's Top Doctors for Cancer Castle Connolly, 2005-2013

Clinical Trials

Gemcitabine in Treating Patients With Recurrent or Refractory Bladder Cancer Start of enrollment: 2000 Sep 01
Withdrawn
Phase 1
Calcitriol and Dexamethasone in Treating Patients With Prostate Cancer Who Have Undergone Surgery or Radiation Therapy Start of enrollment: 2002 Apr 01
Completed
Phase 2
Calcitriol and Dexamethasone Before Radical Prostatectomy in Treating Patients With Localized Adenocarcinoma (Cancer) of the Prostate Start of enrollment: 2002 Sep 01
Terminated
Phase 2
Fulvestrant in Treating Patients With Recurrent Prostate Cancer Start of enrollment: 2004 Jun 01
Terminated
Phase 2
Calcitriol, Ketoconazole, and Dexamethasone in Treating Patients With Metastatic or Unresectable Solid Tumors Start of enrollment: 2004 Nov 01
Completed
Phase 1
Fulvestrant in Treating Patients With Advanced Prostate Cancer Start of enrollment: 2005 Sep 01
Completed
Phase 2
Calcitriol and Dexamethasone in Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy Start of enrollment: 2006 Apr 01
Terminated
Phase 2
Vitamin D in Treating Patients With Prostate Cancer Start of enrollment: 2007 Jun 01
Completed
Phase 2
Calcitriol in Combination With Ketoconazole and Therapeutic Hydrocortisone in Treating Patients With Prostate Cancer Start of enrollment: 2006 Oct 01
Terminated
Phase 1, Phase 2
Ketoconazole, Dexamethasone, and Hydrocortisone in Treating Patients With Prostate Cancer That Did Not Respond to Androgen-Deprivation Therapy Start of enrollment: 2007 Oct 01
Withdrawn
Not Applicable
Cholecalciferol Supplement in Treating Patients With Localized Prostate Cancer Undergoing Observation Start of enrollment: 2009 Apr 08
Completed
Not Applicable
Join now to see all

Publications & Presentations

PubMed

1935 citations
Neoadjuvant Chemotherapy plus Cystectomy Compared with Cystectomy Alone for Locally Advanced Bladder Cancer
H. Barton Grossman, Ronald B. Natale, Catherine M. Tangen, V. O. Speights, Nicholas J. Vogelzang
The New England Journal of Medicine. 2003-08-28
47 citations
Phase II Study of Dutasteride for Recurrent Prostate Cancer During Androgen Deprivation Therapy
Satyan K. Shah, Donald L. Trump, Oliver Sartor, Wei Tan, Gregory E. Wilding
The Journal of Urology. 2009-02-01
40 citations
Important clinical pharmacologic considerations in the use of methadone in cancer patients.
Ettinger Ds, Vitale Pj, Trump Dl
Cancer Treatment Reports. 1979-03-01

Lectures

Breast Cancer Risk Markedly Lower with Serum 25-Hydroxyvitamin D Concentrations ≥60 vs <20 ng/ml (150 vs 50 nmol/L): Pooled Analysis of Two Randomized Trials and a Pro...
Roswell Park Cancer Institute, Buffalo, New York - 8/24/2012

Press Mentions

ImmunSYS, Inc. Announces Formation of Scientific Advisory BoardJune 25th, 2019
Global Gag Rule Will Continue to Harm Young People Seeking Access to Reproductive ChoicesMarch 9th, 2018
Trump to Be Life President?March 4th, 2018
Join now to see all